Hypera Pharma

Hypera S.A.
Formerly	Prátika Industrial; (2001–2008); Hipermarcas S.A.; (2008–2018);
Type	Sociedade Anônima
Traded as	B3: HYPE3; Ibovespa Component
Industry	Pharmaceuticals
Founded	2001; 21 years ago
Headquarters	São Paulo, Brazil
Key people	Breno Oliveira,(CEO)
Products	Drugs; Healthcare; Cosmetics
Revenue	US$ 1.1 billion (2017)
Net income	US$ 297.8 million (2017)
Number of employees	7,515 (Dec 31, 2019)
Subsidiaries
Website	www.hyperapharma.com.br

Hypera Pharma (formerly known as Hypermarcas) is a Brazilian multinational pharmaceutical company headquartered in São Paulo. It is the Brazilian largest pharmaceutical company by market capitalization. The company was formerly known as Hypermarcas, before a corporate name change that was announced in December 2017.^[2] The company was rebranded as Hypera in 2018.

Hypera Pharma's main market segments are Consumer Health, Branded Prescription and Branded Generics.

References[]

^ ^a ^b Terra.com (Portuguese language) Archived 2011-07-06 at the Wayback Machine
^ "Hypermarcas quer crescer até 3% acima do mercado em quatro anos". Valor Econômico (in Brazilian Portuguese). 2017-12-04.

External links[]

Hypera Pharma

[terra-1] Terra.com (Portuguese language) Archived 2011-07-06 at the Wayback Machine

[2] "Hypermarcas quer crescer até 3% acima do mercado em quatro anos". Valor Econômico (in Brazilian Portuguese). 2017-12-04.

[1]

[2]


Formerly	Prátika Industrial (2001–2008) Hipermarcas S.A. (2008–2018)
Type	Sociedade Anônima
Traded as	B3: HYPE3 Ibovespa Component
Industry	Pharmaceuticals
Founded	2001; 21 years ago (2001)
Headquarters	São Paulo, Brazil
Key people	Breno Oliveira,(CEO)
Products	Drugs Healthcare Cosmetics
Revenue	US$ 1.1 billion (2017)^[1]
Net income	US$ 297.8 million (2017)^[1]
Number of employees	7,515 (Dec 31, 2019)
Subsidiaries
Website	www.hyperapharma.com.br